Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo

Recent studies have suggested that C-MYC may be an excellent therapeutic cancer target and a number of new agents targeting C-MYC are in preclinical development. Given most therapeutic regimes would combine C-MYC inhibition with genotoxic damage, it is important to assess the importance of C-MYC fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Phesse, T J, Myant, K B, Cole, A M, Ridgway, R A, Pearson, H, Muncan, V, van den Brink, G R, Vousden, K H, Sears, R, Vassilev, L T, Clarke, A R, Sansom, O J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013513/
https://www.ncbi.nlm.nih.gov/pubmed/24583641
http://dx.doi.org/10.1038/cdd.2014.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013513/
https://www.ncbi.nlm.nih.gov/pubmed/24583641
http://dx.doi.org/10.1038/cdd.2014.15

Ejemplares similares